Artificial intelligence (AI) is learning to mimic expert scientists to improve processing steps needed to produce cell therapies. Multiply Labs and Stanford University’s Laboratory for Cell and Gene Medicine (LCGM) are working together to increase cell therapy processing more quickly than currently possible. The process involves teaching robots to mimic the exact motions of expert cell processing scientists, which can be achieved through the use of these robots. The use of this technology can reduce costs by about 70% and potentially increase the error rates and process throughput for life-saving therapies. However, the challenge of AI is unpredictable as it is based on probabilistic algorithms, requiring a safety check to ensure predictability. The AIs potential applications include the pharmaceutical industry, which is particularly suited for this type of automation.
Source
This post was brought to you by Wrk. Our bot looks for news related to automation and post daily.
